Page last updated: 2024-10-18

imidazole and Tay-Sachs Disease

imidazole has been researched along with Tay-Sachs Disease in 2 studies

imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.

Tay-Sachs Disease: An autosomal recessive neurodegenerative disorder characterized by the onset in infancy of an exaggerated startle response, followed by paralysis, dementia, and blindness. It is caused by mutation in the alpha subunit of the HEXOSAMINIDASE A resulting in lipid-laden ganglion cells. It is also known as the B variant (with increased HEXOSAMINIDASE B but absence of hexosaminidase A) and is strongly associated with Ashkenazic Jewish ancestry.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BESSMAN, SP2
BALDWIN, R1

Other Studies

2 other studies available for imidazole and Tay-Sachs Disease

ArticleYear
Imidazole aminoaciduria in cerebromacular degeneration.
    Science (New York, N.Y.), 1962, Mar-09, Volume: 135, Issue:3506

    Topics: Amino Acids; Body Fluids; Histidine; Humans; Imidazoles; Lipidoses; Methylhistidines; Tay-Sachs Dise

1962
IMIDAZOLE AMINO ACIDURIA. A BIOCHEMICAL DEFECT IN JUVENILE TAY-SACHS DISEASE.
    Revista de neuro-psiquiatria, 1964, Volume: 27

    Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Child; Gangliosidoses, GM2; Genetics, Medical; His

1964